CNTA
Centessa Pharmaceuticals
CNTA
CNTA
117 hedge funds and large institutions have $1.62B invested in Centessa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
-12
Holders Change %
-9.3%
% of All Funds
1.57%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
19
Increased
45
Reduced
34
Closed
31
Calls
$8.54M
Puts
$2.02M
Net Calls
+$6.52M
Net Calls Change
+$15.9M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$19.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$19M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.1M |
| 4 |
Millennium Management
New York
|
+$13.8M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$13.1M |
Top Sellers
| 1 |
Holocene Advisors
New York
|
-$32.4M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$26.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$24.9M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$17.6M |
| 5 |
Morgan Stanley
New York
|
-$15M |
